ALBT - Avalon GloboCare Corp. Total Company Value
The visual price representation available on the page, where the indicator is 31.56, is combined with compliance with biosafety standards for waste disposal. Avalon GloboCare (ALBT) is developing advanced cancer diagnostic methods through blood vesicle analysis, utilizing unique exosome isolation techniques. However, Avalon GloboCare (ALBT) faces a capital shortage and potential delays in obtaining operating licenses for its laboratories.
Avalon GloboCare Corp. (ALBT) - metric breakdowns and financial figures
The analyst evaluates the credit profile of Avalon GloboCare (ALBT) through the lens of total liabilities and assets. Business resilience is supported by high-tech imaging and cell therapy for hospitals in the US and China. The enterprise value on this chart reflects the total acquisition cost, summing market capitalization with debt minus liquidity. This metric measures the real price of the business, eliminating net equity distortions. It is critical for investors to correlate the trend of this indicator with the revenue growth rates from innovative ancillary services.